AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Aldravone 1.5mg Injection

Prescription Icon
Prescription Required

Marketer

All Molecules

Salt Composition

Edaravone (1.5mg)

Overview Aldravone 1.5mg Injection

For individuals with amyotrophic lateral sclerosis (ALS), a debilitating neuromuscular disorder, Neurox 1.5mg Injection offers therapeutic intervention. This antioxidant medication mitigates nerve cell deterioration, potentially slowing disease advancement. Administered intravenously by a qualified medical professional, Neurox 1.5mg Injection is reserved for patients unable to take oral medication. Dosage and treatment duration must adhere strictly to the physician's instructions. Missed doses should be taken as soon as recalled. Commonly reported side effects include cephalalgia, ecchymosis, and impaired ambulation. Localized injection site reactions (pain, erythema, edema) are also possible but typically self-limiting. Persistent or bothersome side effects warrant medical consultation. Immediate medical attention is crucial for any allergic response, such as pruritus, or facial, lip, or tongue swelling.

Uses of Aldravone 1.5mg Injection

Lou Gehrig's disease

Major Benefits of Aldravone 1.5mg Injection:

This medication will be administered by your physician or their designated nurse; please do not attempt self-medication.

Common Side effects of Aldravone 1.5mg Injection:

  • Bruise
  • Walking difficulties
  • Headache
  • Injection site reactions (pain, swelling, redness)

How to use Aldravone 1.5mg Injection:

This medication will be administered by your healthcare provider; self-medication is strongly discouraged.

How Aldravone 1.5mg Injection works:

Neuro-Guard 1.5mg Injection offers antioxidant support, promoting neurological health and safeguarding nerve cells. Its mechanism involves mitigating the damage inflicted by free radicals, thus delaying the onset of amyotrophic lateral sclerosis (ALS) symptom progression. This effect is achieved through the restoration of oxidative balance within the brain.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The safety of alcohol consumption alongside Aldravone 1.5mg Injection is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Aldravone 1.5mg Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the benefits against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Aldravone 1.5mg Injection with breastfeeding are unavailable. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Aldravone 1.5mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding Aldravone 1.5mg Injection's use in individuals with renal impairment is scarce. Physician consultation is advised.

LiverLiverCAUTION

For patients with severe hepatic impairment, administering Aldravone 1.5mg Injection requires careful consideration and potential dose modification. Medical advice is recommended. Data regarding Aldravone 1.5mg Injection use in such patients is limited. Dosage changes are not advised for individuals with mild or moderate liver dysfunction.

What if you forget to take Aldravone 1.5mg Injection :

NA

Facts to Know About Aldravone 1.5mg Injection

LabelValue
Chemical Classification Pyrazolone Derivatives
Developing Habits No.
Type of Therapy Neuroscience of the Central Nervous System
Actions Cognitive enhancer

FAQs on Aldravone 1.5mg Injection

Aldravone 1.5mg Injection may cause confusion, headache, and gait disturbance. Less frequent side effects include skin rash and itching, breathing problems (shortness of breath, chest tightness, wheezing, cough, especially in asthmatics), and fungal infections.
Aldravone 1.5mg Injection, an intravenous solution, is administered over one hour by a healthcare professional in a clinic or hospital setting. Initially, it's given daily for the first 14 days of a 28-day cycle. Subsequent cycles involve daily administration for the first 10 days of a 28-day cycle. Dosage frequency is determined by your physician based on your individual response.
Aldravone 1.5mg Injection treats amyotrophic lateral sclerosis (ALS), a disease causing progressive nerve cell death that controls muscle movement, leading to muscle wasting and weakness. It slows the nerve damage that worsens ALS symptoms.
Tell your doctor or pharmacist if you're allergic to edaravone, sodium bisulfite, other medications, or any Aldravone 1.5mg Injection ingredient. Before taking Aldravone, inform your doctor about all other medications, vitamins, and supplements you're using or plan to use; dose adjustments or monitoring may be necessary. Also, tell your doctor about any history of asthma, and if you are pregnant, plan to become pregnant, or are breastfeeding. Contact your doctor immediately if you become pregnant while on edaravone.
While ALS prevention remains unproven due to a lack of supporting studies, mitigating risk factors may lessen the likelihood of developing the disease. These factors include smoking, and exposure to pesticides and insecticides. Military service has also been identified as a potential risk factor.
People of Caucasian and non-Hispanic descent are most frequently diagnosed with ALS. Between 5 and 10 percent of cases are familial, inherited from parents. Onset can occur at any age, though symptoms typically appear between ages 55 and 75. Men are slightly more prone than women, although this disparity diminishes with age. Research indicates military veterans may have a 1.5 to 2 times greater risk due to potential wartime toxin exposure.
Exposure to toxins during combat or intense physical exertion may contribute to the heightened ALS risk observed in some veterans and athletes.
ALS often begins with subtle muscle problems. These might include twitches in the limbs or tongue, cramps, muscle stiffness, and weakness in an arm, leg, neck, or diaphragm. Speech difficulties (slurred or nasal) and swallowing problems are also common early signs. The initial symptom may be hand or arm weakness, hindering simple actions like buttoning a shirt. Alternatively, leg weakness may be the first sign, leading to gait difficulties, tripping, or stumbling.
Aldravone 1.5mg Injection
475
MRP 550
13% off